Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Tenax Therapeutics, Inc.

Clinical trials sponsored by Tenax Therapeutics, Inc., explained in plain language.

Tenax Therapeutics, Inc. TENX NASDAQ

A specialty pharmaceutical company developing treatments for cardiovascular and pulmonary diseases.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 1 Not yet finished but already full! 2 Completed 1 Terminated 1

Heart failure drug levosimendan tested for long-term safety in 35 patients

Disease control Completed

This study looked at the safety of using levosimendan over a longer period in people who have both pulmonary hypertension and heart failure with preserved ejection fraction. 35 patients who had already been in a related study received the drug and were monitored for side effects.…

Phase: PHASE2 • Sponsor: Tenax Therapeutics, Inc. • Aim: Disease control

Last updated Jun 27, 2026 12:23 UTC